Logo image of 1ANTM.MI

ELEVANCE HEALTH INC (1ANTM.MI) Stock Fundamental Analysis

Europe - BIT:1ANTM - US0367521038 - Common Stock

261.5 EUR
+20.9 (+8.69%)
Last: 9/15/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to 1ANTM. 1ANTM was compared to 28 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of 1ANTM while its profitability can be described as average. 1ANTM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year 1ANTM was profitable.
1ANTM had a positive operating cash flow in the past year.
1ANTM had positive earnings in each of the past 5 years.
Each year in the past 5 years 1ANTM had a positive operating cash flow.
1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCF1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

1ANTM has a better Return On Assets (4.40%) than 74.07% of its industry peers.
The Return On Equity of 1ANTM (12.26%) is better than 70.37% of its industry peers.
With a decent Return On Invested Capital value of 5.90%, 1ANTM is doing good in the industry, outperforming 62.96% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1ANTM is in line with the industry average of 5.66%.
Industry RankSector Rank
ROA 4.4%
ROE 12.26%
ROIC 5.9%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1ANTM.MI Yearly ROA, ROE, ROIC1ANTM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

1ANTM has a Profit Margin (2.83%) which is in line with its industry peers.
1ANTM's Profit Margin has declined in the last couple of years.
1ANTM has a Operating Margin (4.60%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of 1ANTM has declined.
Industry RankSector Rank
OM 4.6%
PM (TTM) 2.83%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
1ANTM.MI Yearly Profit, Operating, Gross Margins1ANTM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

3

2. Health

2.1 Basic Checks

1ANTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, 1ANTM has less shares outstanding
The number of shares outstanding for 1ANTM has been reduced compared to 5 years ago.
1ANTM has a worse debt/assets ratio than last year.
1ANTM.MI Yearly Shares Outstanding1ANTM.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
1ANTM.MI Yearly Total Debt VS Total Assets1ANTM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

1ANTM has a debt to FCF ratio of 5.70. This is a neutral value as 1ANTM would need 5.70 years to pay back of all of its debts.
1ANTM has a better Debt to FCF ratio (5.70) than 74.07% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that 1ANTM is somewhat dependend on debt financing.
The Debt to Equity ratio of 1ANTM (0.65) is better than 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.7
Altman-Z N/A
ROIC/WACC0.78
WACC7.59%
1ANTM.MI Yearly LT Debt VS Equity VS FCF1ANTM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
1ANTM.MI Yearly Current Assets VS Current Liabilites1ANTM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

6

3. Growth

3.1 Past

1ANTM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.64%.
1ANTM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.17% yearly.
The Revenue has grown by 10.21% in the past year. This is quite good.
Measured over the past years, 1ANTM shows a quite strong growth in Revenue. The Revenue has been growing by 11.14% on average per year.
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%

3.2 Future

Based on estimates for the next years, 1ANTM will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.57% on average per year.
Based on estimates for the next years, 1ANTM will show a quite strong growth in Revenue. The Revenue will grow by 8.96% on average per year.
EPS Next Y5.39%
EPS Next 2Y9.72%
EPS Next 3Y11.61%
EPS Next 5Y12.57%
Revenue Next Year12.17%
Revenue Next 2Y8.92%
Revenue Next 3Y8.04%
Revenue Next 5Y8.96%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
1ANTM.MI Yearly Revenue VS Estimates1ANTM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B 250B
1ANTM.MI Yearly EPS VS Estimates1ANTM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.03, the valuation of 1ANTM can be described as very reasonable.
Based on the Price/Earnings ratio, 1ANTM is valued cheaply inside the industry as 92.59% of the companies are valued more expensively.
1ANTM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.27.
With a Price/Forward Earnings ratio of 7.51, the valuation of 1ANTM can be described as very cheap.
Based on the Price/Forward Earnings ratio, 1ANTM is valued cheaply inside the industry as 92.59% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.77. 1ANTM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.03
Fwd PE 7.51
1ANTM.MI Price Earnings VS Forward Price Earnings1ANTM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ANTM is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ANTM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 12.69
EV/EBITDA 8.29
1ANTM.MI Per share data1ANTM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.68
PEG (5Y)0.81
EPS Next 2Y9.72%
EPS Next 3Y11.61%

5

5. Dividend

5.1 Amount

1ANTM has a Yearly Dividend Yield of 2.42%.
Compared to an average industry Dividend Yield of 2.57, 1ANTM pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, 1ANTM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.42%

5.2 History

On average, the dividend of 1ANTM grows each year by 15.34%, which is quite nice.
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

28.40% of the earnings are spent on dividend by 1ANTM. This is a low number and sustainable payout ratio.
The dividend of 1ANTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.4%
EPS Next 2Y9.72%
EPS Next 3Y11.61%
1ANTM.MI Yearly Income VS Free CF VS Dividend1ANTM.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
1ANTM.MI Dividend Payout.1ANTM.MI Dividend Payout, showing the Payout Ratio.1ANTM.MI Dividend Payout.PayoutRetained Earnings

ELEVANCE HEALTH INC

BIT:1ANTM (9/15/2025, 7:00:00 PM)

261.5

+20.9 (+8.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-17 2025-07-17/bmo
Earnings (Next)10-15 2025-10-15/amc
Inst Owners92.69%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap58.88B
Analysts79.29
Price Target419.89 (60.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.42%
Yearly Dividend5.74
Dividend Growth(5Y)15.34%
DP28.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.93%
Min EPS beat(2)-2.26%
Max EPS beat(2)4.12%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)8
Avg EPS beat(12)-0.08%
EPS beat(16)11
Avg EPS beat(16)0.72%
Revenue beat(2)2
Avg Revenue beat(2)2.87%
Min Revenue beat(2)1.45%
Max Revenue beat(2)4.3%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)-13.09%
PT rev (3m)-13.09%
EPS NQ rev (1m)-42.57%
EPS NQ rev (3m)-42.57%
EPS NY rev (1m)0.54%
EPS NY rev (3m)0.54%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)0.5%
Revenue NY rev (1m)1.8%
Revenue NY rev (3m)1.8%
Valuation
Industry RankSector Rank
PE 9.03
Fwd PE 7.51
P/S 0.35
P/FCF 12.69
P/OCF 10.48
P/B 1.54
P/tB 17.38
EV/EBITDA 8.29
EPS(TTM)28.95
EY11.07%
EPS(NY)34.8
Fwd EY13.31%
FCF(TTM)20.61
FCFY7.88%
OCF(TTM)24.96
OCFY9.54%
SpS736.98
BVpS170.26
TBVpS15.05
PEG (NY)1.68
PEG (5Y)0.81
Profitability
Industry RankSector Rank
ROA 4.4%
ROE 12.26%
ROCE 7.72%
ROIC 5.9%
ROICexc 6.38%
ROICexgc 11.77%
OM 4.6%
PM (TTM) 2.83%
GM N/A
FCFM 2.8%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexcg growth 3Y-5.49%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.7
Debt/EBITDA 2.8
Cap/Depr 75.47%
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion 62.96%
Profit Quality 98.73%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.59%
ROIC/WACC0.78
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
EPS Next Y5.39%
EPS Next 2Y9.72%
EPS Next 3Y11.61%
EPS Next 5Y12.57%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
Revenue Next Year12.17%
Revenue Next 2Y8.92%
Revenue Next 3Y8.04%
Revenue Next 5Y8.96%
EBIT growth 1Y-14.33%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year11.18%
EBIT Next 3Y10.33%
EBIT Next 5Y11.33%
FCF growth 1Y-49.94%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-45.8%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%